Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-184138
Filing Date
2015-05-12
Accepted
2015-05-12 16:56:39
Documents
8
Period of Report
2015-06-01
Effectiveness Date
2015-05-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A d910772ddef14a.htm DEF 14A 693017
2 GRAPHIC g910772pc_pg003a.jpg GRAPHIC 80553
3 GRAPHIC g910772pc_pg003bnew.jpg GRAPHIC 2404
4 GRAPHIC g910772pc_pg003cnew.jpg GRAPHIC 929
5 GRAPHIC g910772pc_pg003dnew1.jpg GRAPHIC 15068
6 GRAPHIC g910772pc_pg003enew2.jpg GRAPHIC 10569
7 GRAPHIC g910772pc_pg003fnew.jpg GRAPHIC 1244
8 GRAPHIC g910772pc_pg004.jpg GRAPHIC 2871
  Complete submission text file 0001193125-15-184138.txt   851688
Mailing Address 16200 WCR 18E LOVELAND CO 80537
Business Address 16200 WCR 18E LOVELAND CO 80537 (970) 635-0346
Rosewind CORP (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: CO | Fiscal Year End: 0831
Type: DEF 14A | Act: 34 | File No.: 000-53121 | Film No.: 15855151
SIC: 2834 Pharmaceutical Preparations